The Allergy & Asthma Network praised three major pharmaceutical companies, AstraZeneca, Boehringer Ingelheim and GSK, that announced they will enact a $35 price cap on their inhaler products ...

Eur Respir J. 2019;54 (3):1900900. Price DB, et al. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. 2018;11:193-204. GOLD.

AstraZeneca's drive to rebuild its portfolio of new medicines received a boost with positive results for an experimental biotech drug for severe asthma that the company previously flagged as a ...

Major pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at $35 per month, a move that offers relief but doesn't fully address the larger issue of high drug ...

GSK plc’s GSK Specialty Medicines segment includes medicines that prevent and treat diseases like HIV, cancer, asthma and immune-inflammation diseases like lupus. Specialty Medicines now represents ...

Papi A, et al. Relationship of inhaled corticosteroid adherence to asthma exacerbations in patients with moderate-to-severe asthma. J Allergy Clin Immunol Pract. 2018; 6 (6): 1989-98.e3.

AstraZeneca hopes to convince doctors its experimental injection for severe asthma has an edge over two approved rivals after clinical trials data on Monday showed it worked well when given just ...

AstraZeneca’s Tezspire receives European approval to treat severe asthma Cambridge, UK Thursday, September 22, 2022, 09:00 Hrs [IST] AstraZeneca’s Tezspire (tezepelumab) has been approved in the ...

CHMP recommends marketing authorization for AstraZeneca’s Tezspire in EU to treat severe asthma Cambridge, UK Tuesday, July 26, 2022, 09:00 Hrs [IST] AstraZeneca’s Tezspire (tezepelumab) has been ...

AstraZeneca is conducting a non-interventional, prospective study titled ‘A Non-interventional, Prospective Study With Benralizumab to Investigate Clinical Outcome Based on Standard of Care ...

In this activity, learn from leading experts in allergy and pulmonology about the pathophysiology of mucus plugging in severe asthma, how to identify mucus plugs, and the impacts of current and ...

LABAs, which are also used to treat the more serious lung condition chronic obstructive pulmonary disease (COPD), are blockbuster products for the companies with Advair's sales reaching about $7.8 ...